Literature DB >> 24057698

Vascular cutaneous anomalies in children: malformations and hemangiomas.

O Enjolras1, J B Mulliken.   

Abstract

The vast majority of cutaneous vascular anomalies in infants and children are either malformations or hemangiomas. Vascular malformations are subgrouped, based on channel morphology and rheology: slow-flow (capillary, lymphatic, venous, or combined-complex types) and fast-flow malformations (ectasia, aneurysm, fistula, or arteriovenous anomalies). Noninvasive radiologic techniques, especially ultrasonography with Doppler flow studies and magnetic resonance imaging, serve to document the extent and flow characteristics. Management depends on the type of malformation: laser for capillary malformations; surgical excision for lymphatic malformations; compression, sclerotherapy, and resection for venous malformations; and embolization and/or surgical resection for arteriovenous fistulae/malformations. Hemangiomas are the most common tumors of infancy. The life cycle is divided into three phases: proliferating, involuting, and involuted. Most hemangiomas do not require treatment, although drug therapy is indicated for endangering or life-threatening hemangiomas. Corticosteroids (either systemic or local) and alpha-2a interferon are currently the most effective agents. Surgical resection of problematic hemangiomas can be undertaken during infancy, the preschool years, or childhood.

Entities:  

Year:  1996        PMID: 24057698     DOI: 10.1007/BF00497795

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  18 in total

1.  Biological classification of soft-tissue vascular anomalies: MR correlation.

Authors:  J S Meyer; F A Hoffer; P D Barnes; J B Mulliken
Journal:  AJR Am J Roentgenol       Date:  1991-09       Impact factor: 3.959

2.  Symptomatic vascular malformations: ethanol embolotherapy.

Authors:  W F Yakes; D K Haas; S H Parker; M D Gibson; K D Hopper; J S Mulligan; P H Pevsner; J C Johns; T E Carter
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

Review 3.  Surgical treatment of predominantly venous defects.

Authors:  D A Loose
Journal:  Semin Vasc Surg       Date:  1993-12       Impact factor: 1.000

4.  Management of alarming hemangiomas in infancy: a review of 25 cases.

Authors:  O Enjolras; M C Riche; J J Merland; J P Escande
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

5.  Treatment of cutaneous hemangiomas by the flashlamp-pumped pulsed dye laser: prospective analysis.

Authors:  J M Garden; A D Bakus; A S Paller
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

6.  Venous and arteriovenous vascular malformations: diagnostic and therapeutic considerations regarding 239 patients observed in the 1978-1991 period.

Authors:  A M Raso; P Rispoli; M Trogolo; G Sisto; P L Castagno
Journal:  J Cardiovasc Surg (Torino)       Date:  1993-02       Impact factor: 1.888

Review 7.  Infantile subglottic hemangiomas. An update.

Authors:  A H Shikhani; M M Jones; B R Marsh; M J Holliday
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jul-Aug       Impact factor: 1.547

8.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

9.  The treatment of capillary-venous malformations using a new fibrosing agent.

Authors:  M C Riche; E Hadjean; P Tran-Ba-Huy; J J Merland
Journal:  Plast Reconstr Surg       Date:  1983-05       Impact factor: 4.730

Review 10.  Benign lymphangioendothelioma.

Authors:  G S Herron; R V Rouse; J C Kosek; B R Smoller; B M Egbert
Journal:  J Am Acad Dermatol       Date:  1994-08       Impact factor: 11.527

View more
  5 in total

Review 1.  Venous malformation: update on aetiopathogenesis, diagnosis and management.

Authors:  A Dompmartin; M Vikkula; L M Boon
Journal:  Phlebology       Date:  2010-10       Impact factor: 1.740

2.  Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas").

Authors:  Pascal Brouillard; Laurence M Boon; John B Mulliken; Odile Enjolras; Michella Ghassibé; Matthew L Warman; O T Tan; Bjorn R Olsen; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2002-02-13       Impact factor: 11.025

3.  Combined endovascular and surgical approach for the treatment of palpebral arteriovenous malformations: experience of a single center.

Authors:  F Clarençon; R Blanc; C-J Lin; C Mounayer; O Galatoire; S Morax; J Moret; M Piotin
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

4.  Multiple widespread blue nodules: a clinicopathological case.

Authors:  R Atkar; R Verdolini
Journal:  Case Rep Dermatol       Date:  2012-01-04

Review 5.  Effects of sclerosing agents on head and neck hemangiomas: A systematic review.

Authors:  Rúbia-Teodoro Stuepp; Fernanda-Marcello Scotti; Gilberto Melo; Etiene-de Andrade Munhoz; Filipe Modolo
Journal:  J Clin Exp Dent       Date:  2019-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.